Capital Royalty backs Valeritas with $100m
The healthcare-focused debt fund manager has provider a term loan to insulin device manufacturer Valeritas.
5 June 2013•1 min read
PRIVATE CREDIT
Register to unlock this content
Daily global private credit news and market intelligence- Expertly curated insights that keep you ahead of the market
- Faster, data-driven decision making powered by our AI interface, 'Ask PEI'
- Access to proprietary research and reports
- Selected fund performance and investor activity data